Highlights Hana Pharm Co., Ltd.

Equities

A293480

KR7293480000

End-of-day quote Korea S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
13,100 ^KRW	+2.50%		-1.13%	-6.09%

2023	Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore	MT
2023	Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hyphens Pharma Pte. Ltd. Signs an Exclusive Sub-License and Supply Agreement with Hana Pharm Co., Ltd. to Develop and Commercialise Byfavo® 20mg in Singapore	17/05/23	CI
Hana Pharm Receives Market Approval for Byfavo (Remimazolam) in Procedural Sedation in South Korea	31/08/21	CI
Hana Pharm Informs PAION AG About the Launch of Byfavo™ (Remimazolam) for the Use in General Anesthesia in South Korea	07/04/21	CI
Hana Pharm Co., Ltd's Equity Buyback announced on August 19, 2019, has expired.	17/02/20	CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20	CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20	CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20	CI
Hana Pharm Co., Ltd's Equity Buyback announced on August 6, 2019, has expired with 87,239 shares, representing 0.54% for KRW 1,997.13 million.	04/02/20	CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 9, 2019.	08/01/20	CI
Hana Pharm Co., Ltd's Equity Buyback announced on July 9, 2019, has expired.	07/01/20	CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 26, 2019.	30/10/19	CI
Hana Pharm Co., Ltd's Equity Buyback announced on July 26, 2019, has expired with 84,312 shares, representing 0.53% for KRW 1,997.08 million.	29/10/19	CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	19/08/19	CI
Hana Pharm Co., Ltd authorizes a Buyback Plan.	18/08/19	CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06/08/19	CI
Hana Pharm Co., Ltd authorizes a Buyback Plan.	05/08/19	CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	26/07/19	CI
Hana Pharm Co., Ltd authorizes a Buyback Plan.	25/07/19	CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	09/07/19	CI
Hana Pharm Co., Ltd authorizes a Buyback Plan.	08/07/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hana Pharm Co., Ltd.

Equities

A293480

KR7293480000

Highlights

Filters